Cite
HARVARD Citation
Ferris, R. et al. (n.d.). Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Journal for immunotherapy of cancer. p. . [Online].